Results 311 to 320 of about 1,125,014 (336)
Some of the next articles are maybe not open access.
AJN, American Journal of Nursing, 1982
Prostatic cancer is predominantly found in elderly males and is becoming increasingly important as life expectancy rises. It is now the second or third most common malignant disease in men in Western countries with one in ten men developing clinical evidence of the disease. However, only a third of diagnosed patients die of the condition, for mortality
Rhoda Tigert Hoeft, Anne G. Jones
openaire +3 more sources
Prostatic cancer is predominantly found in elderly males and is becoming increasingly important as life expectancy rises. It is now the second or third most common malignant disease in men in Western countries with one in ten men developing clinical evidence of the disease. However, only a third of diagnosed patients die of the condition, for mortality
Rhoda Tigert Hoeft, Anne G. Jones
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1992
To the Editor. —The study by Johansson et al 1 is of limited relevance because their selection criteria resulted in a study group that is not representative of the patient population with early prostate cancer. Their study group included an inordinately high proportion of men over the age of 75 years, most of whom had low-grade tumors too small to be ...
openaire +3 more sources
To the Editor. —The study by Johansson et al 1 is of limited relevance because their selection criteria resulted in a study group that is not representative of the patient population with early prostate cancer. Their study group included an inordinately high proportion of men over the age of 75 years, most of whom had low-grade tumors too small to be ...
openaire +3 more sources
Seminars in Oncology Nursing, 1993
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +3 more sources
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +3 more sources
Scandinavian Journal of Urology and Nephrology, 2000
Prostate cancer is an ideal candidate for chemoprevention because of its high prevalence, long latency time, hormone dependency, precursor lesions, and its unique serum marker, PSA. Chemoprevention is the administration of drugs or other agents which aim to prevent the induction or inhibit/delay cancer progression.
Schulman, Claude +4 more
openaire +5 more sources
Prostate cancer is an ideal candidate for chemoprevention because of its high prevalence, long latency time, hormone dependency, precursor lesions, and its unique serum marker, PSA. Chemoprevention is the administration of drugs or other agents which aim to prevent the induction or inhibit/delay cancer progression.
Schulman, Claude +4 more
openaire +5 more sources
Endocrinology and Metabolism Clinics of North America, 1994
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
openaire +4 more sources
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
openaire +4 more sources
JAMA: The Journal of the American Medical Association, 1976
IN HIS treatise on diseases of the urinary tract, Samuel D. Gross, 1 in 1855, noted that cancer of the prostate was considered to be extremely rare. He sided with this point of view and, except for anodynes and leeches applied to the perineum, considered cancer of the prostate as not amenable to treatment. Toward the end of the 19th century, individual
openaire +3 more sources
IN HIS treatise on diseases of the urinary tract, Samuel D. Gross, 1 in 1855, noted that cancer of the prostate was considered to be extremely rare. He sided with this point of view and, except for anodynes and leeches applied to the perineum, considered cancer of the prostate as not amenable to treatment. Toward the end of the 19th century, individual
openaire +3 more sources
Intrapatient heterogeneity in prostate cancer
Nature Reviews Urology, 2015A newly published study used whole-genome sequencing of multiple prostate tumour foci from several patients with intermediate-risk prostate cancer to track evolutionary patterns and delineate the marked intrapatient molecular heterogeneity of this disease.
Beltran, Himisha, Demichelis, Francesca
openaire +3 more sources
The Lancet, 2008
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
Radiology, 1947
In view of the recent work on the treatment of carcinoma of the prostate by estrogens on the one hand and by castration on the other, sometimes supplemented by irradiation of the suprarenals or the pituitary, the following report of 25 cases treated in the past ten years is presented.
openaire +3 more sources
In view of the recent work on the treatment of carcinoma of the prostate by estrogens on the one hand and by castration on the other, sometimes supplemented by irradiation of the suprarenals or the pituitary, the following report of 25 cases treated in the past ten years is presented.
openaire +3 more sources
Medical Clinics of North America, 1999
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources